EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency
Marinomed Biotech AG announces unanimous approval of the restructuring
plan by creditors
14-Nov-2024 / 14:34 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the
Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS
Group AG.
The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════
Korneuburg, Austria, November 14, 2024 - Marinomed Biotech AG (VSE:MARI)
announces that the creditors' assembly unanimously approved the
restructuring plan presented at the final court hearing at the Korneuburg
Regional Court on November 14, 2024. The established quota is 30%, payable
in several tranches within two years. 5% is to be deposited as a cash
quota. The liquidity required for the repayment of the quotas is to be
partially funded through the sale of the Carragelose business unit of
Marinomed Biotech AG. A super quota of up to a further 7% will be
distributed if milestone payments from the sale of the Carragelose
business within two years exceed the planned amount. Confirmation of the
restructuring plan and termination of the proceedings are subject, among
other things, to the payment of the 5% cash deposit and a standstill
declaration from the European Investment Bank (EIB). The Company will
provide information on further developments.
+++ End of ad-hoc announcement +++
End of Inside Information
══════════════════════════════════════════════════════════════════════════
14-Nov-2024 CET/CEST News transmitted by EQS Group AG. www.eqs.com
══════════════════════════════════════════════════════════════════════════
Language: English
Company: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Phone: +43 2262 90300
E-mail: office@marinomed.com
Internet: www.marinomed.com
ISIN: ATMARINOMED6
WKN: A2N9MM
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt,
Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange
(Official Market)
EQS News ID: 2030405
End of Announcement EQS News Service
2030405 14-Nov-2024 CET/CEST
